Feature | Radiation Dose Management | September 04, 2019 | By Mukta Acharya

Monitoring Radiation in the Workplace

This article ran as an introductory chart on Radiation Dose Monitoring in the September issue. You can view the comparison chart here

Wearing personal radiation measurement badges to measure dose exposure is crucial.

Wearing personal radiation measurement badges to measure dose exposure is crucial.

Mukta Acharya

Mukta Acharya

Doctors and technologists are exposed to on-the-job radiation often on a daily basis. It is critical to be aware of how much radiation the clinician is being exposed to, and some of the best methods of monitoring that exposure.

Everyone is exposed to radiation from benign sources such as cosmic rays, radon, microwaves and cell phones. However, higher-energy short-wave radiation in many occupational sources can penetrate and disrupt living cells and increase cancer risk, so exposure must be monitored. The risk of cancer from radiation exposure reportedly increases as the dose of radiation increases. Anyone who works in a setting with a known radiation source is at risk.

Any amount of radiation can be harmful in theory, but it’s generally accepted that low exposures carry low risk. When it comes to chronic radiation, however, experts don’t always agree on a safe level. This is especially true since some radiation effects, including cancer, may not show for years or decades after an individual has stopped being exposed. The Occupational Safety and Health Administration (OSHA) does have published standards, but they don’t answer the question of what is too much for each person.

What is Dosimetry?

Dosimetry is the calculation of the absorbed dose in tissue resulting from exposure to ionizing radiation. Dosimetry monitoring is the practice of wearing personal radiation measurement badges (dosimeters) to measure the amount of dose exposure. These badges provide readings about the dose of ionizing radiation an individual receives. Dose measurements and history are captured and stored. These dose reports help to monitor the safety of the workers and the workplace.

Dosimetry monitoring services enable customers to monitor and track individual radiation dose in compliance with radiation safety regulations. Most services also include compliance, recordkeeping and reporting capabilities that help manage an efficient safety program. Typically, technologists wear badges for a period of time and at the end of the wear period, they ship them to the service provider to be read. Staff typically receive replacement badges prior to the end of the wear period so there is no gap in dose monitoring. The dose data and dose reports are calculated by the dosimetry service provider and are made available to the customers, usually through an online portal.

Providing customers dose data to help protect employees from potentially harmful radiation is the most important reason for dosimetry services. Accreditations and regulations across industries at state, federal and government levels internationally also place certain radiation monitoring requirements on organizations with ionizing radiation sources. Having a dosimetry service program provides data that can be used to identify situations of overexposure and take corrective actions to minimize radiation exposure in the future. It helps improve safety and provide peace of mind to the customer that their workplace and employees are safe.

Many organizations institute radiation safety programs with dose monitoring services as a protection from future litigation. While the health risk of radiation exposure is purportedly low, the fact that it’s still a possibility creates a liability risk for employers. Consider cancer; for men there is a 39.66 percent probability they’ll develop cancer in their lifetime. With such a high probability, it would be wise to understand exactly how much exposure each employee has — if any — and to document that measurement systematically to show it never exceeded thresholds. This would be valuable information in any future legal discovery.

Recommended Frequency

Frequency of radiation monitoring can vary based on the work environment and the needs of the facilty. Dosimeters can be read daily, weekly, monthly or quarterly, and the customer will usually work with the dosimetry service provider to select the desired frequency of reads.

Radiation dose monitoring strategies and tracking can be overwhelming, especially for smaller offices and practices that don’t have the dedicated resources for managing such a program. It requires due diligence with a clear process for long-term documentation and recordkeeping, along with an understanding of the required compliance. It often requires dedicated resources, and can also get complex and expensive. The good news is that there are simple and cost-effective dosimetry monitoring services available to organizations of all sizes that simplify radiation safety with a streamlined process. When organizations outsource the process, they gain freedom from the radiation dose tracking burden and overhead and can instead focus on their core competency.

Service Providers

When researching service providers, consider the technology and types of dosimeters offered, as well as accreditations and certifications, the access you will have to radiation consultants, ease of access to the dose reports and any type of hidden fees that could evolve. Also consider the provider’s experience in dosimetry, ability to provide expert technical support and customer service. 

Mukta Acharya is director of marketing, field and safety instruments, for Thermo Fisher Scientific.

This article ran as an introductory chart on Radiation Dose Monitoring in the September issue. You can view the comparison chart here

Related Content

According to recent studies, an increase in the COVID-19 positivity rate correlates to an increase in mortality from non-coronavirus-related diseases. This includes breast cancer, and researchers believe fear of contracting the virus compels patients to stay home instead of completing their post-lumpectomy radiotherapy regimens.

Image courtesy of Zeiss

News | Radiation Therapy | December 21, 2020
December 21, 2020 — According to recent studies, an increase in the...
Older patients with hormone receptor-positive breast cancer who did not receive radiation therapy after breast-conserving surgery had higher rates of local recurrence but similar 10-year survival rates when compared to patients who received postoperative radiation therapy, according to updated 10-year data from the PRIME II study, presented at the 2020 San Antonio Breast Cancer Symposium

Getty Images

News | Radiation Therapy | December 15, 2020
December 15, 2020 — Older patients with hormone receptor-positive breast cancer who did not receive radiation therapy
Bayer Radiology is announcing Radimetrics v3.0, the newest evolution of its enterprise dose management application.
News | Radiation Dose Management | December 11, 2020
December 11, 2020 — Bayer Radiology is announcing Radimetrics v3.0, the newest evolution of its enterprise dose manag
A new study finds that significant symptoms in young and Black patients are more likely to be under-recognized

Getty Images

News | Radiation Therapy | December 10, 2020
December 10, 2020 — Physicians did not recognize side effects from...
Post-neoadjuvant therapy changes in metabolic metrics from PET/MRI and morphologic metrics from CT were associated with pathologic response and overall survival in patients with pancreatic ductal adenocarcinoma

Pre-treatment (A-C) and post-treatment (D-F) images after eight cycles of systemic FOLFIRINOX and consolidative chemoradiation. Baseline CA 19-9 was 145 U/ml. Pre-treatment whole body axial fused PET/MRI showed FDG avid lesion in body of pancreas (arrow, A) with SUVmax 7.1 and SUVgluc 8.0. Lesion was hypo-enhancing on axial contrast-enhanced T1-weighted (T1W) MR image (arrow, B) from focused abdominal PET/MRI and on CT (arrow, C). Pre-treatment CT tumor volume was 10.3 cm3. Post-treatment whole body axial fused PET/MRI showed complete metabolic response (arrow D) with SUVmax 1.9 and SUVgluc 1.9. Lesion was indistinct on axial contrast-enhanced T1W MRI (arrow, E) and CT (arrow, F), and there was upstream pancreatic parenchymal atrophy. Post-treatment CT tumor volume was 0.46 cm3. There was normalization of CA 19-9. Relative change in SUVmax (ΔSUVgluc) was -73%, and relative change in SUVgluc (ΔSUVgluc) was -76%. Based on change in tumor size, response was categorized as partial response per RECIST. Relative change in tumor volume (ΔTvol) was -96%. Pathology showed major pathologic response (College of American Pathologists score 1.) Images courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | PET-MRI | December 10, 2020
December 10, 2020 — According to an open...
A new hybrid X-ray detector developed by the University of Surrey outperforms commercial devices — and could lead to more accurate cancer therapy.
News | X-Ray | December 03, 2020
December 3, 2020 — A new hybrid X-ray detector deve
For men with early-stage prostate cancer, choices about initial treatment carry varying risks of "financial toxicity," reports a study in The Journal of Urology, Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.

Getty Images

News | Prostate Cancer | December 02, 2020
December 2, 2020 — ...